Predicts failure of noninvasive ventilation (NIV), meaning the need for intubation, in patients with hypoxemic respiratory failure, from five bedside findings after 1 hour of NIV. The updated HACOR adds six findings from before NIV.
How to read the result
| HACOR after 1 hour of NIV | Risk | In the original test cohort |
|---|
| 5 or less | Lower | 78.1% did not need intubation (negative predictive value) |
| Above 5 | High | 87.2% needed intubation (positive predictive value) |
At a cut-off of 5, sensitivity was 72.6% and specificity 90.2% (AUC 0.88 at 1 hour). In an observational subgroup of patients above 5 at 1 hour whose NIV failed, hospital mortality was lower with intubation within 12 hours of starting NIV than with later intubation (66% against 79%); this was not a randomized comparison. The score should not decide intubation on its own; the 2022 authors note that its benefit still has to be shown in randomized trials.
| Updated HACOR after 1-2 hours of NIV | Risk | NIV failure, 2022 cohorts |
|---|
| 7 or less | Low | 12.4% |
| 7.5-10.5 | Moderate | 38.2% |
| 11-14 | High | 67.1% |
| Above 14 | Very high | 83.7% |
Scoring
| Variable | Points |
|---|
| Heart rate | 120/min or less: 0; 121/min or more: 1 |
| pH | 7.35 or higher: 0; 7.30-7.34: 2; 7.25-7.29: 3; below 7.25: 4 |
| Glasgow Coma Scale | 15: 0; 13-14: 2; 11-12: 5; 10 or less: 10 |
| PaO2/FiO2, mmHg | 201 or more: 0; 176-200: 2; 151-175: 3; 126-150: 4; 101-125: 5; 100 or less: 6 |
| Respiratory rate | 30/min or less: 0; 31-35: 1; 36-40: 2; 41-45: 3; 46 or more: 4 |
Updated HACOR = HACOR + 0.5 × SOFA + 2.5 (pneumonia) − 4 (cardiogenic pulmonary edema)
+ 3 (ARDS from a pulmonary cause) + 1.5 (immunosuppression) + 2.5 (septic shock)
The original score runs from 0 to 25. In the updated score, the SOFA score and the five conditions are those present before NIV; the HACOR items are measured after 1-2 hours of NIV.
Validation
Duan and colleagues derived the scale in 449 patients receiving NIV for hypoxemia in a respiratory ICU (NIV failure 47.8%) and confirmed it in 358 more (39.4%); accuracy for NIV failure stayed above 80% across diagnoses, ages and severity, and at 1, 12, 24 and 48 hours. The 2022 update came from 1451 patients in 9 hospitals in Chongqing and was validated in 728 patients from 8 other hospitals in China and 1 in Turkey; at 1-2 hours its AUC was 0.85 and 0.78, against 0.80 and 0.71 for the original score. The 2022 study excluded hypercapnic failure, COPD exacerbations, and NIV after extubation or after high-flow oxygen failure.
References
- Duan J, Han X, Bai L, et al. Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients. Intensive Care Med. 2017;43(2):192-199. PMID 27812731
- Duan J, Chen L, Liu X, et al. An updated HACOR score for predicting the failure of noninvasive ventilation: a multicenter prospective observational study. Crit Care. 2022;26(1):196. PMID 35786223